Jw Pharmaceutical

This study tested whether taking two medications together (JW0108 and C2407) can safely lower LDL or 'bad' cholesterol in people with dyslipidemia. A total of 145 adults participated. The main goal was to measure the percent change in LDL-C levels from the start of the study.

This study looked at adults with high cholesterol who switched from a single statin drug to a combination pill containing pitavastatin and ezetimibe. Over 6,900 participants were followed for 24 weeks to see how much their LDL (bad) cholesterol dropped. The goal was to see if the…

This study tested a new medicine called JW0201 in 200 adults with type 2 diabetes whose blood sugar was not well controlled with their current two-drug regimen. Participants received either JW0201 or a placebo added to their existing treatment. The main goal was to see if JW0201 …

This study tested whether adding a new medicine called JW0201 helps people with type 2 diabetes who are not well controlled on two other diabetes drugs. About 196 adults took either JW0201 or a placebo for 24 weeks. The main goal was to see if JW0201 lowers blood sugar levels mor…

This study looked at how well the drug Livalozet lowers cholesterol in people with high cholesterol, comparing those who also have diabetes to those who don't. Over 1,500 adults took part, and the main goal was to see how much their LDL (bad) cholesterol dropped after 24 weeks. T…

This study tested a new drug called epaminurad against an existing gout medication, febuxostat, in 612 adults with gout. The goal was to see which drug better lowers uric acid levels below 6 mg/dL. Gout is a painful condition caused by uric acid buildup, and this trial aimed to f…

This study tested a new single pill that combines two common heart medications (pitavastatin and valsartan) against taking them separately. 52 healthy men participated to see how the drugs are absorbed and processed by the body. The goal was to find out if the combination pill wo…

This study looked at how two drugs, epaminurad and C2406, affect each other in the body and whether they are safe together. It involved 18 healthy adults aged 19 to 50. The goal was to measure drug levels and check for side effects, not to treat any disease.

This early-stage study tested the safety and drug interaction of epaminurad and naproxen in 57 healthy adults aged 19-50. Participants received the drugs to measure how the body processes them. The goal was to gather safety data, not to treat any disease.

This study tested the safety and how the body absorbs three drugs (JW0104, C2402, and JW0105) in 60 healthy adults under fasting conditions. Participants received single doses of the drugs alone or together to measure drug levels in the blood. The goal was to gather early safety …

This study looked at how healthy men absorb, break down, and eliminate the drug epaminurad. Eight men took a single dose, and researchers measured the drug and its byproducts in blood, urine, and stool. The goal was to understand the drug's path through the body, not to treat any…

This early-stage study tested the safety and how the body processes a drug called epaminurad in 34 healthy adults aged 19 to 55. Participants received a single dose under fasting conditions. The goal was to measure drug levels in the blood, not to treat any disease.